---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-026854"
form_type: "8-K"
ticker: "NOVT"
cik: "0001076930"
company_name: "NOVANTA INC"
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T04:21:13.480007+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Novanta recasts segment reporting into Automation Enabling Technologies and Medical Solutions

## Summary
- Two new segments replace prior three-segment structure (Precision Medicine & Manufacturing, Robotics & Automation, Medical Solutions).
- Automation Enabling Technologies FY2024 revenue $490.6M, operating income $106.4M (up 10.5% YoY).
- Medical Solutions FY2024 revenue $458.6M (up 19.9% YoY), operating income $57.5M (down 9.1% YoY).
- Total FY2024 revenue $949.2M, operating income $110.6M; gross margin 44.4% vs 45.4% in FY2023.
- Q4 2024 Medical Solutions operating income dropped to $7.0M from $15.8M a year earlier.

## SEC filing metadata
- accession: 0000950170-25-026854
- form_type: 8-K
- ticker: NOVT
- cik: 0001076930
- company_name: NOVANTA INC
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1076930/000095017025026854/0000950170-25-026854-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1076930/000095017025026854/novt-20250225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-026854
- JSON: https://secwatch.observer/filing/0000950170-25-026854.json
- Plain text: https://secwatch.observer/filing/0000950170-25-026854.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.